---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-24-000035"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:12:52.432109+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics stockholders approve ESPP and re-elect directors at annual meeting

## Summary
- 8,522,632 shares represented (~62.15% quorum) at July 17, 2024 annual meeting.
- Daniel Donovan and Thomas I.H. Dubin re-elected as Class I directors until 2027.
- Stockholders approved 2024 Employee Stock Purchase Plan (ESPP) with 6.6M for, 103k against.
- EisnerAmper LLP ratified as independent auditor for fiscal year ending December 31, 2024.

## SEC filing metadata
- accession: 0001567264-24-000035
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/0001567264-24-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/intensity-20240717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-24-000035
- JSON: https://secwatch.observer/filing/0001567264-24-000035.json
- Plain text: https://secwatch.observer/filing/0001567264-24-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.